Pfizer to sell its Thane Plant

Drug Major Pfizer has announced that it is transferring its Thane plant to Vidhi Research


The deal is worth Rs 178 crore

Pfizer Ltd has informed BSE that it has entered into a Business Transfer Agreement (BTA) for the transfer of the Company's business at the Thane Plant as a going concern to Vidhi Research and Development, in accordance with the terms of the agreement for a consideration of Rs 178 crore.

Upon the conclusion of the BTA, all current workmen at the Thane Plant shall be transferred to the buyer so as to facilitate manufacturing operations, the company added.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email